Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Verrica Pharmaceuticals Inc.

Clinical trials sponsored by Verrica Pharmaceuticals Inc., explained in plain language.

Verrica Pharmaceuticals Inc. VRCA NASDAQ

Dermatology company developing treatments for skin conditions.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet recruiting 1

Can a blister beetle extract banish common warts? phase 3 trial investigates

Disease control Not yet recruiting

This Phase 3 trial tests YCANTH, a topical solution containing cantharidin (a substance from blister beetles), against a placebo for treating common warts. About 300 people aged 2 and older with at least one wart on their body (excluding certain areas) will receive either the act…

Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control

Last updated Jun 27, 2026 13:08 UTC